Medipal Holdings Corp (7459) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medipal Holdings Corp (7459:JPX), powered by AI.

Current Price
¥2,770
P/E Ratio
14.3
Market Cap
577.5B
Sector
Healthcare
What is the Medipal Holdings Corp stock price forecast?

Medipal Holdings Corp is currently trading at ¥2,770. View real-time AI analysis on Alpha Lenz.

What is Medipal Holdings Corp insider trading activity?

View the latest insider trading data for Medipal Holdings Corp on Alpha Lenz.

What is Medipal Holdings Corp's P/E ratio?

Medipal Holdings Corp's P/E ratio is 14.3.

Medipal Holdings Corp

¥2.77K
JPX7459
Ask about Medipal Holdings Corp's future dividend policy...
Alpha Chat Insight

Medipal Holdings Corp trades at a P/E of 14.3 (undervalued) with modest ROE of 6.6%.

Ask for details

Company Overview

Medipal Holdings Corp is a leading company in Japan's pharmaceutical distribution industry. As a comprehensive pharmaceutical wholesaler, its primary function is to ensure the efficient distribution and availability of drugs, medical devices, and healthcare-related products across Japan. Medipal Holdings Corp operates in the healthcare, animal health, and cosmetics sectors, serving as a crucial link between manufacturers and end consumers, such as hospitals, pharmacies, and clinics. The company is recognized for its advanced logistics and supply chain solutions, which are vital in maintaining the integrity and efficiency of pharmaceutical distribution. By maintaining a robust network and leveraging technological innovations, Medipal plays a significant role in the healthcare market, contributing to the accessibility and availability of essential medicines and healthcare products in Japan. Its operations are critical, especially in times of public health emergencies, ensuring that healthcare providers receive the necessary supplies without delay.

CEOMr. Shuichi Watanabe
SectorHealthcare
IndustryMedical Distribution
Employees13,061

Company Statistics

(FY 2025)

Profile

Market Cap¥577.50B
Revenue¥3,671.33B
Shares Out0.00
Employees13,061

Margins

Gross6.97%
EBITDA2.28%
Operating1.51%
Pre-Tax2.09%
Net1.40%

Valuation

P/E14.34
P/B0.93
EV/Sales0.16
EV/EBITDA5.43
P/FCF12.00

Growth (CAGR)

Rev 3Yr3.71%
Rev 5Yr2.45%
Op Inc 3Yr6.82%
Op Inc 5Yr0.92%
Net Inc 3Yr9.55%
Net Inc 5Yr0.12%

Returns

ROA2.84%
ROE6.60%
ROIC4.24%

Financial Health

Cash & Cash Equivalents¥261.41B
Net Debt¥805.63B
Debt/Equity140.78%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Medipal Holdings Corp (Healthcare) Stock Forecast & Analysis ¥2,770 | Alpha Lenz